Daniel Markwardt
Impact in
- Hepatology top 10%
- Liver Disease and Transplantation
- Hepatocellular Carcinoma Treatment and Prognosis
-
- Acute Kidney Injury Research
- Chronic Kidney Disease and Diabetes
Papers in
-
- Liver Disease and Transplantation 4
- Hepatocellular Carcinoma Treatment and Prognosis 1
- Oncology 4
- Pancreatic and Hepatic Oncology Research 3
- Co-authors
- Alexander L. Gerbes (4 shared papers)Christian J. Steib (3 shared papers)Julia Wendon (1 shared paper)Frederik Nevens (1 shared paper)Jonel Trebicka (1 shared paper)Flemming Bendtsen (1 shared paper)Andreas Benesic (1 shared paper)Elisabet García (1 shared paper)
- Journals
- JCO Precision Oncology (1 paper)European Journal of Gastroenterology & Hepatology (1 paper)Medical Oncology (1 paper)Journal of Cancer Research and Clinical Oncology (1 paper)Digestive and Liver Disease (1 paper)
- Partner nations
- GermanyUnited KingdomSwitzerland
In The Last Decade
Daniel Markwardt
7 papers receiving 121 citations
Peers
Comparison fields: 5 of 32
- Hepatology 101
- Nephrology 40
- Epidemiology 60
- Pharmacology 15
- Critical Care and Intensive Care Medicine 6
Countries citing papers authored by Daniel Markwardt
This map shows the geographic impact of Daniel Markwardt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Markwardt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Markwardt more than expected).
Fields of papers citing papers by Daniel Markwardt
This network shows the impact of papers produced by Daniel Markwardt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Markwardt. The network helps show where Daniel Markwardt may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Markwardt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 72 | |
| 2 | 2022 | 19 | |
| 3 | 2020 | 13 | |
| 4 | 2019 | 8 | |
| 5 | 2019 | 7 | |
| 6 | 2022 | 1 | |
| 7 | 2023 | 1 | |
| 8 | 2025 | 0 |
About Daniel Markwardt
Daniel Markwardt is a scholar working on Hepatology, Oncology, Epidemiology, Infectious Diseases and Nephrology, having authored 8 papers that have together received 121 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (4 papers), Liver Disease and Transplantation (4 papers), Pancreatic and Hepatic Oncology Research (3 papers), Cancer Genomics and Diagnostics (2 papers), Hepatocellular Carcinoma Treatment and Prognosis (1 paper), Chronic Kidney Disease and Diabetes (1 paper), Genetic factors in colorectal cancer (1 paper) and Clostridium difficile and Clostridium perfringens research (1 paper). The work is most often cited by research in Hepatology (101 citations), Nephrology (40 citations), Epidemiology (60 citations), Pharmacology (15 citations) and Critical Care and Intensive Care Medicine (6 citations). Daniel Markwardt has collaborated with scholars based in Germany, United Kingdom and Switzerland. Frequent co-authors include Alexander L. Gerbes, Christian J. Steib, Julia Wendon, Frederik Nevens, Jonel Trebicka, Flemming Bendtsen, Andreas Benesic, Elisabet García, Lesca M. Holdt and Daniel Teupser. Their work appears in journals such as JCO Precision Oncology, European Journal of Gastroenterology & Hepatology, Medical Oncology, Journal of Cancer Research and Clinical Oncology and Digestive and Liver Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.